Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 1 Characteristics of included studies
Author | Year | Type of study | Follow up (months) | Arthroscopic assisted | Suspensory loop (single or double) or HP | Implant types | Implant removal time (month) | Age | Type of AC injury | Male (%) | Time interval from injury to surgery (days) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stam L | 1991 | Case series | 46.8 | N | Single | Dacron | – | 40 | III–V | 73.9 | 4.4 | Complications |
Dimakopoulos P | 2006 | Case series | 33.2 | N | Double | Ethibond | – | 33.5 | III/V | 91.2 | 10 | CMS, complications |
Ryhanen J | 2006 | Case series | 12 | N | Single | C-hook | 3 | 37 | III | – | – | Complications |
Choi S | 2008 | Case series | 41.2 | N | Single | Ethibond | – | 33.5 | III–V | 80 | – | VAS, complications |
Murena L | 2009 | Case series | 31 | N | Double | Endobutton | – | 33.3 | III–V | 93.8 | 4.3 | CMS, complications |
Greiner S | 2009 | Case series | 70 | N | Single | PDS | – | 35.3 | III–V | 86 | – | CMS, complications |
Salzmann GM | 2010 | Case series | 24 | Y | Double | Tightrope | – | 37.5 | III–V | 91.3 | 11.3 | CMS, VAS, complications |
Scheibel M | 2011 | Case series | 26.5 | Y | Double | Tightrope | – | 38.6 | III/V | 92.9 | 7.3 | CMS, complications |
Wai HF | 2011 | Case series | 12 | N | Double | Endobutton | – | 42.8 | III–V | 86.7 | 6.5 | CMS, VAS, complications |
El Sallakh SA | 2012 | Case series | 24 | Y | Single | Tightrope | – | 30 | V | 90 | – | CMS, complications |
Sandmann GH | 2012 | Case series | 32 | N | Double | Tightrope | – | 39 | III–V | 91 | 5 | CMS, VAS, complications |
Beris A | 2013 | Case series | 18.25 | N | Single | Tightrope | – | 27.5 | III–IV | 75 | 5 | CMS, VAS, complications |
Kraus N | 2013 | Cohort | 24 | N | Double (V) | Tightrope | – | 37.7 | V | 93.3 | – | CMS, complications |
Kraus N | 2013 | Cohort | 24 | N | Double | Tightrope | – | 40.9 | V | 92.3 | – | CMS, complications |
Venjakob AJ | 2013 | Case series | 58 | Y | Double | Tightrope | – | – | III–V | 91.3 | – | CMS, VAS, complications |
Spolitil M | 2014 | Case series | 5 | Y | Single | Tightrope | – | 33 | III–V | 84.2 | – | CMS, VAS, complications |
Acar MA | 2015 | Case series | 13.6 | Y | Single | Ziploop | – | 43.4 | III | 92.3 | 7.92 | CMS, VAS, complications |
Katsenis DL | 2015 | Case series | 42 | N | Single | Flipptack | – | 35.5 | IV–V | 76 | 4.2 | CMS, complications |
Pan Z | 2015 | Case series | 24 | Y | Single | Endobutton | – | 26 | III/V | 72.7 | 6.1 | CMS, complications |
Shin SJ | 2015 | Case series | 25.6 | Y | Single | Tightrope | – | 45.4 | III–V | 94.4 | 6.1 | CMS, complications |
Struhl S | 2015 | Case series | 62.4 | Y | Single | Endobutton | – | 45.7 | III–V | 88.9 | 13 | CMS, complications |
Koukakis A | 2008 | Case series | 10.6 | N | HP | HP | 2–3 | – | III–V | – | 7.3 | CMS, VAS, complications |
Salem KH | 2009 | Case series | 30 | N | HP | HP | 2.5 | 41 | III–V | 92 | 7 | CMS, complications |
Kienast B | 2011 | Case series | 36 | N | HP | HP | 3 | 38.4 | III–V | 83.7 | 6 | Complications |
Francesco AD | 2012 | Case series | 12 | N | HP | HP | 3 | 27.5 | III/V | 66.7 | 3.5 | CMS, complications |
Gille J | 2013 | Case series | 7 | Y | HP | HP | – | – | III/V | – | – | CMS, complications |
Sarrafan N | 2012 | Case series | 12 | N | HP | HP | 8 | 38 | III | 90 | – | VAS, complications |
Guizzi P | 2012 | Case series | 21 | N | HP | HP | – | – | III | – | – | CMS, complications |
Heideken JV | 2013 | Case control | 32 | N | HP | HP | 4 | 40 | V | 77.3 | 0.3 | CMS, VAS, complications |
Jafary D | 2014 | Case series | 19 | N | HP | HP | 5 | 40.3 | III/V | 91.7 | – | CMS, complications |
Steinbacher G | 2014 | Case series | 50.4 | N | HP | HP | 4 | 29 | III | 73.7 | – | VAS, complications |
Kumar N | 2015 | Case series | 23.5 | N | HP | HP | 4 | 34.24 | III | 100 | 9.06 | CMS, complications |
Escher A | 2011 | Cohort | 31.2 | N | Single vs HP | PDS | 4 | 42.3 | V | 88.5 | 8.5 | VAS, CMS, complications |
Andreani L | 2014 | Cohort | 3 | N | Single vs HP | Tightrope | 3 | – | IV–VI | 100 | 7.2 | CMS, complications |
Jensen G | 2014 | Cohort | 48 | Y | Double vs HP | Tightrope | 3 | 39 | III/V | 91.1 | – | VAS, CMS, complications |
Metzlaff S | 2016 | Cohort | 32 | Y | Single vs HP | FlippTack | 3 | 37.6 | III/V | 79.5 | 14 | CMS, complications |
Yoon JP | 2015 | Cohort | – | Y | Double vs HP | LIGASTIC | 2 | 40 | V | 78.6 | 9.2 | VAS, CMS, complications |